NCT06599190

Brief Summary

Fifty female athletes suffering from stress incontinence (SUI) will participate in this study. They will be selected from El Zohour Club, New Cairo City.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Aug 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

August 20, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2024

Completed
Last Updated

March 6, 2025

Status Verified

March 1, 2025

Enrollment Period

3 months

First QC Date

August 18, 2024

Last Update Submit

March 4, 2025

Conditions

Keywords

stress incontinence, and female athelete

Outcome Measures

Primary Outcomes (2)

  • Assessment of urine loss

    Pad testing will be used to quantify the volume of urine loss by weighing an absorbent pad before and after some type of leakage provocation. The test will start with weighting clean empty pad in grams. Then, it will be used until next time and weighted again. The weight of the used pad will be subtracted from the weight of the empty pad so the net result will determine the amount of leakage.

    24 hours pad test for12 weeks

  • assesment of pelvic floor muscle contraction and tonning

    The measurements will be taken in crock-lying position with a full bladder, neutral lumbar spine. The ultrasound transducer will be inserted transversely directly superior to the symphysis pubis, probe is tilted 60 degrees from vertical (Arab, 2010). Every female will perform 3 maximal PFM contractions so that displacement of the bladder wall, because of a PFM contraction, could be measured.

    12 weeks

Secondary Outcomes (1)

  • Assessment of symptoms and health related quality of life

    12 weeks

Study Arms (2)

Group (A) (Control group)

ACTIVE COMPARATOR

consists of 25 female athletes. They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months.

Other: pelvic floor exercises, nutritional instructions

Group (B) (Study group)

EXPERIMENTAL

consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months.

Other: abdominal hypopressive exercises, pelvic floor exercises, nutritional instructions

Interventions

They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months.

Group (A) (Control group)

consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months.

Group (B) (Study group)

Eligibility Criteria

Age14 Years - 18 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Female athletes suffering from SUI.
  • They will be diagnosed with SUI using bladder stress test.
  • Their ages will range from 14-18 years old.
  • Their body mass index (BMI) will range from 18.5-24.9 kg/m2.
  • They are single females.

You may not qualify if:

  • The female athlete will be excluded if they had:
  • Urinary tract infection.
  • Family history of genito-urinary tract cancer.
  • Diabetes mellitus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

El Zohour Club

New Cairo, Cairo Governorate, 470001, Egypt

Location

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Abeer ElDeeb, Professor

    professor doctor

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
single
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: They will be randomly distributed into 2 groups equal in numbers: Group (A) (Control group) consists of 25 female athletes. They will receive nutritional instructions and pelvic floor muscle exercises three sessions/week for 3 months. Group (B) (Study group) consists of 25 female athletes. They will receive the same treatment for the control group and abdominal hypopressive exercises three sessions/week of 30 mins per week for 3 months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

August 18, 2024

First Posted

September 19, 2024

Study Start

August 20, 2024

Primary Completion

November 20, 2024

Study Completion

December 22, 2024

Last Updated

March 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

not sharing

Locations